Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice - Sorbonne Université
Conference Papers Year : 2019

Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice

K Ray K
  • Function : Author
M Schoonen
  • Function : Author
L Annemans
  • Function : Author
A van Hout B
  • Function : Author
M Sibartie
  • Function : Author
I Bridges
  • Function : Author
E Bruckert
  • Function : Author
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases

Domains

Life Sciences [q-bio]

Maryse Guerin  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03970100

Submitted on : Thursday, February 2, 2023-3:56:25 PM

Last modification on : Thursday, December 14, 2023-1:50:38 PM

No file

Dates and versions

hal-03970100 , version 1 (02-02-2023)

Identifiers

  • HAL Id : hal-03970100 , version 1

Cite

K Ray K, M Schoonen, L Annemans, A van Hout B, M Sibartie, et al.. Effectiveness of evolocumab for patients with familial hypercholesteraemia (FH) in European clinical practice. Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, Aug 2019, Paris, France. ⟨hal-03970100⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

ICAN SORBONNE-UNIVERSITE SU-MEDECINE IHU_ICAN
4 View
0 Download

Share

More